Strategies that target mutant p53 expression, focusing on degradation of mutated protein, restoring the wild type activity, forming p53 complexes with other proteins, or interfering with p53-related signaling pathways can potentially help prevent and control cancer [14, 38]. Here, TP53 is linked to cancer.